Association between a functional genetic polymorphism (rs2230199) and age-related macular degeneration risk: A meta-analysis

Genetics and Molecular Research

Volumn 14, Issue 4, 2015, Pages 12567-12576

  Zhang, M X ^a,b   Zhao, X F ^c   Ren, Y C ^a,b   Geng, T T ^b,e   Yang, H ^a,b   Feng, T ^b   Jin, T B ^a,b,d   Chen, C ^a,b  

^a NORTHWEST UNIVERSITY   (China)

^b National Engineering Research Center for Miniaturized Detection System   (China)

^c General Hospital Chinese Armed Police   (China)

^d XIZANG MINZU UNIVERSITY   (China)

^e XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Age related macular degeneration; Meta analysis; Polymorphism; Rs2230199

Indexed keywords

AGE RELATED MACULAR DEGENERATION; ALLELE; ARTICLE; C3 GENE; CASE CONTROL STUDY; CORRELATIONAL STUDY; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; RISK FACTOR; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETICS; MACULAR DEGENERATION; MALE; META ANALYSIS;

COMPLEMENT COMPONENT C3;

ALLELES; CASE-CONTROL STUDIES; COMPLEMENT C3; DATABASES, GENETIC; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MACULAR DEGENERATION; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84944754011     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.October.16.24     Document Type: Article

References (38)

1. Anderson DH, Mullins RF, Hageman GS and Johnson LV (2002). A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 134: 411-431.
2. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, et al. (2010). The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog. Retin. Eye Res. 29: 95-112.
3. Congdon N, O'Colmain B, Klaver CC, Klein R, et al. (2004). Causes and prevalence of visual impairment among adults in the United States. Arch. Ophthalmol. 122: 477.
4. Cui L, Zhou H, Yu J, Sun E, et al. (2010). Noncoding variant in the complement factor H gene and risk of exudative age-related macular degeneration in a Chinese population. Invest. Ophthalmol. Vis. Sci. 51: 1116-1120.
5. De Jong PT (2006). Age-related macular degeneration. N. Engl. J. Med. 355: 1474-1485.
6. DerSimonian R and Laird N (1986). Meta-analysis in clinical trials. Control. Clin. Trials 7: 177-188.
7. Ding X, Patel M and Chan CC (2009). Molecular pathology of age-related macular degeneration. Prog. Retin. Eye Res. 28: 1-18.
8. Duvvari MR, Paun CC, Buitendijk GH, Saksens NT, et al. (2014). Analysis of rare variants in the C3 gene in patients with age-related macular degeneration. PloS One 9: e94165.
9. Edwards AO, Fridley BL, James KM, Sharma AK, et al. (2008). Evaluation of clustering and genotype distribution for replication in genome wide association studies: the age-related eye disease study. PLoS One 3: e3813.
10. Gehrs KM, Jackson JR, Brown EN, Allikmets R, et al. (2010). Complement, age-related macular degeneration and a vision of the future. Arch. Ophthalmol. 128: 349-358.
11. Gold B, Merriam JE, Zernant J, Hancox LS, et al. (2006). Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 38: 458-462.
12. Hageman GS, Anderson DH, Johnson LV, Hancox LS, et al. (2005). A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A. 102: 7227-7232.
13. Liu X, Zhao P, Tang S, Lu F, et al. (2010). Association study of complement factor H, C2, CFB, and C3 and age-related macular degeneration in a Han Chinese population. Retina 30: 1177-1184.
14. Maller JB, Fagerness JA, Reynolds RC, Neale BM, et al. (2007). Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat. Genet. 39: 1200-1201.
15. Mantel N and Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J. Natl. Cancer Inst. 22: 719-48.
16. McKay GJ, Dasari S, Patterson CC, Chakravarthy U, et al. (2010). Complement component 3: an assessment of association with AMD and analysis of gene-gene and gene-environment interactions in a Northern Irish cohort. Mol. Vis. 16: 194.
17. Mousavi M and Armstrong RA (2013). Genetic risk factors and age-related macular degeneration (AMD). J. Optom. 6: 176-184.
18. Munafò MR and Flint J (2004). Meta-analysis of genetic association studies. Trends Genet. 20: 439-444.
19. Park KH, Fridley BL, Ryu E, Tosakulwong N, et al. (2009). Complement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration. Invest. Opthamol. Vis. Sci. 50: 3386-3393.
20. Pei XT, Li XX, Bao YZ, Yu WZ, et al. (2009). Association of c3 gene polymorphisms with neovascular age-related macular degeneration in a chinese population. Curr. Eye Res. 34: 615-622.
21. Peter I, Huggins GS, Ordovas JM, Haan M, et al. (2011). Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study. Am. J. Opthamol. 152: 1005-1013. e1001.
22. Raychaudhuri S, Iartchouk O, Chin K, Tan PL, et al. (2011). A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat. Genet. 43: 1232-1236.
23. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, et al. (2004). Global data on visual impairment in the year 2002. Bull. World Health Organ. 82: 844-851.
24. Reynolds R, Hartnett ME, Atkinson JP, Giclas PC, et al. (2009). Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest. Opthamo. Vis. Sci. 50: 5818-5827.
25. Ricklin D, Hajishengallis G, Yang K and Lambris JD (2010). Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11: 785-797.
26. Scholl HP, Charbel Issa P, Walier M, Janzer S, et al. (2008). Systemic complement activation in age-related macular degeneration. PloS One 3: e2593.
27. Scholl HP, Fleckenstein M, Fritsche LG, Schmitz-Valckenberg S, et al. (2009). CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS One 4: e7418.
28. Seddon JM, Yu Y, Miller EC, Reynolds R, et al. (2013). Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat. Genet. 45: 1366-1370.
29. Seitsonen SP, Onkamo P, Peng G, Xiong M, et al. (2008). Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration. PloS One 3: e3833.
30. Spencer KL, Olson LM, Anderson BM, Schnetz-Boutaud N, et al. (2008). C3 R102G polymorphism increases risk of age-related macular degeneration. Hum. Mol. Genet. 17: 1821-1824.
31. Tian J, Yu W, Qin X, Fang K, et al. (2012). Association of genetic polymorphisms and age-related macular degeneration in Chinese population. Invest. Opthamol. Vis. Sci. 53: 4262-4269.
32. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, et al. (1995). The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 102: 205-210.
33. Wu L, Tao Q, Chen W, Wang Z, et al. (2013). Association between polymorphisms of complement pathway genes and age-related macular degeneration in a Chinese population. Invest. Opthamol. Vis. Sci. 54: 170-174.
34. Yanagisawa S, Kondo N, Miki A, Matsumiya W, et al. (2011). A common complement C3 variant is associated with protection against wet age-related macular degeneration in a Japanese population. PloS One 6: e28847.
35. Yates JR, Sepp T, Matharu BK, Khan JC, et al. (2007). Complement C3 variant and the risk of age-related macular degeneration. N. Engl. J. Med. 357: 553-561
36. Yu L and Chen J (2012). Association of MTHFR Ala222Val (rs1801133) polymorphism and breast cancer susceptibility: An update meta-analysis based on 51 research studies. Diagn. Pathol. 7: 171.
37. Yu Y, Reynolds R, Fagerness J, Rosner B, et al. (2011). Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Invest. Opthamol. Vis. Sci. 52: 4663-4670.
38. Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137.